CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- SC 13D/A Stake Beneficial Ownership Report
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,337 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 79 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,639 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and Treasurer gave up 2,738 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 4,345 shares (to pay taxes)
- 4 Open-market sale CFO and Treasurer sold 1,674 shares at $21.96 ($36,763)
- 4 Open-market sale President and COO sold 1,594 shares at $21.96 ($35,006)
- 4 Open-market sale Chief Scientific Officer sold 1,503 shares at $21.96 ($33,007)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Scientific Officer sold 563 shares at $22.83 ($12,855)
- 4 Open-market sale President and COO sold 715 shares at $22.83 ($16,326)
- 4 Open-market sale Chief Executive Officer sold 2,313 shares at $22.83 ($52,813)
- 4 Open-market sale CFO and Treasurer sold 733 shares at $22.83 ($16,737)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes CFO and Treasurer gave up 1,412 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 6,719 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 1,337 shares (to pay taxes)
- 10-Q Report Quarterly Report
Page 10 of 34 · 670 filings